SCHEMBL2581290

SCHEMBL2581290

NC(=O)c1ccc(F)c(C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.47
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
ERN1 O75460 1/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
KEAP1 Q14145 1/20 0.41
LCK P06239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3086810 0.88 PARP1 (0.50) PARP1CES2CES1ERN1CYP3A4
SCHEMBL336060 0.85 KDM4E (0.52) CES2CES1CYP3A4HSD17B10TSHR
SCHEMBL392941 0.84 DGAT1 (0.48) PARP1CES2CES1CYP3A4HSD17B10
SCHEMBL27952405 0.84 LMNA (0.46) CES2CES1ERN1HSD17B10TSHR
SCHEMBL4358318 0.83 TDP1 (0.55) CES2CES1CYP3A4HSD17B10POLB
SCHEMBL10316500 0.82 PARP1 (0.46) PARP1CES2CES1ERN1HSD17B10
SCHEMBL2224336 0.82 KDM1A (0.42) CES2CES1CYP3A4HSD17B10POLB
SCHEMBL2224340 0.82 KDM1A (0.42) CES2CES1CYP3A4HSD17B10POLB
SCHEMBL6977142 0.82 KDM1A (0.42) CES2CES1CYP3A4HSD17B10POLB
SCHEMBL28221470 0.81 HSD17B10 (0.59) PARP1CYP3A4HSD17B10TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
WO-2008154905-A2 MODIFICATIONS OF THE HISTONE DEACETYLASE INHIBITOR SUBEROYLANILIDE HYDROXAMIC ACID SCHEBO BIOTECH AG (DE) 2008-12-24 WO disclosed
CN-1906155-A Novel hydroxamic acid esters and pharmaceutical use thereof LEO PHARMA AS (DK) 2007-01-31 CN disclosed